PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

dorzolamide

Verify with FDA → · CMS NADAC pricing →

Brand names: Trusopt

Carbonic Anhydrase Inhibitor (Ophthalmic) Rx

Dorzolamide eye drops help lower pressure in the eye. It is used for people with ocular hypertension or open-angle glaucoma.

Drug Pricing (NADAC)

Generic Price

$1.41/unit

Generic Available

Yes (22 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

This medicine treats high pressure inside your eye.

Common side effects

Burning, stinging, or discomfort in the eye right after using the drops, Bitter taste in your mouth, Superficial punctate keratitis (small spots on the surface of the eye)

Key warnings

Dorzolamide contains a sulfonamide.

How It Works

Dorzolamide is a type of medicine called a carbonic anhydrase inhibitor. It works by decreasing the amount of fluid your eye makes. This lowers the pressure inside your eye.

How to Take It

Use one drop in the affected eye(s) three times a day. You can use dorzolamide with other eye drops to lower eye pressure. If you use other eye drops, wait at least 5 minutes between each medicine.

Pregnancy & Breastfeeding

It is not known if dorzolamide is safe to use during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if dorzolamide passes into breast milk.

Missed Dose

If you miss a dose, use it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Storage

Store dorzolamide at room temperature, between 59° to 86°F (15° to 30°C). Protect from light.

Side Effects (from patient reports)

Based on 4,759 FDA adverse event reports.

Treatment not working
1,369
Medicine not effective
704
Using the medicine for something it's not approved for
475
Feeling tired
444
Headache
356
Pain
321
Eye pain
292
Eye irritation
281
Allergic reaction
265
Skin rash
252

FDA Adverse Event Report Analysis

Detailed analysis of 7,422 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

7,422

Death-Related Reports

381

Hospitalization Reports

1,356

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 3,755 (55%)
Male 3,077 (45%)

Age Distribution

0–17 70
18–44 184
45–64 688
65–74 978
75+ 1,776

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 TREATMENT FAILURE 1,369
2 DRUG INEFFECTIVE 704
3 OFF LABEL USE 475
4 FATIGUE 444
5 HEADACHE 356
6 PAIN 321
7 EYE PAIN 292
8 EYE IRRITATION 281
9 HYPERSENSITIVITY 265
10 RASH 252
11 PAIN IN EXTREMITY 251
12 WEIGHT DECREASED 242
13 CONDITION AGGRAVATED 241
14 DYSPNOEA 238
15 DIZZINESS 234

Reactions in Death Reports

DEATH 215
PNEUMONIA 23
RENAL FAILURE 19
ASTHENIA 18
RESPIRATORY FAILURE 17
FALL 16
OFF LABEL USE 16
FATIGUE 15
CHRONIC KIDNEY DISEASE 13
DYSPNOEA 13

Reactions in Hospitalization Reports

FALL 103
PNEUMONIA 91
OFF LABEL USE 89
DYSPNOEA 83
FATIGUE 75
ACUTE KIDNEY INJURY 74
DIARRHOEA 69
ASTHENIA 65
DIZZINESS 64
PAIN 64

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Dorzolamide contains a sulfonamide. Rarely, severe reactions to sulfonamides have happened, even death. If you have signs of a serious reaction or allergy, stop using this medicine right away.

Known Drug Interactions

moderate timolol

7 DRUG INTERACTIONS Potential additive effect of oral carbonic anhydrase inhibitor with dorzolamide hydrochloride and timolol maleate ophthalmic solution. ( 7.7 ) 7.1 Oral Carbonic Anhydrase Inhibitors There is a potential for an additive effect on the known systemic effects of carbonic anhydrase inhibition in patients receiving an oral carbonic anhydrase inhibitor and dorzolamide hydrochloride and timolol maleate ophthalmic solution. The concomitant administration of dorzolamide hydrochloride and timolol maleate ophthalmic solution and oral carbonic anhydrase inhibitors is not recommended.

Mechanism: Using these drugs together can cause their effects to stack up, which may lead to more side effects throughout your body.

What to do: This combination is not recommended, and you should talk to your doctor about other options.

7.2 High-Dose Salicylate Therapy Although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide hydrochloride ophthalmic solution, these disturbances have been reported with oral carbonic anhydrase inhibitors and have, in some instances, resulted in drug interactions (e.g., toxicity associated with high-dose salicylate therapy).

Mechanism: Taking two drugs that both contain dorzolamide can cause the medicine to build up in your body and lead to chemical imbalances in your blood.

What to do: Check with your pharmacist to make sure you are not using two different products that contain the same active ingredient at the same time.

Common Questions

Can I use dorzolamide with other eye drops?
Yes, you can use dorzolamide with other eye drops. Wait at least 5 minutes between each medicine.
What should I do if I experience burning or stinging in my eye?
Burning or stinging is common right after using the drops. If it continues or gets worse, talk to your doctor.
Can dorzolamide cause allergic reactions?
Yes, some people may have an allergic reaction. If you notice any signs of an allergy, stop using the medicine and talk to your doctor.
What if I wear contact lenses?
The drug label does not contain information about contact lenses. Ask your doctor or pharmacist.
Is it okay to drive while using these eye drops?
Dorzolamide can cause blurred vision in some people. Be careful driving or operating machinery until you know how this medicine affects you.
What if I accidentally use too much of the eye drops?
Using too much is unlikely to cause serious problems. If you are concerned, contact your doctor or pharmacist.
How long can I use dorzolamide after opening the bottle?
You can use dorzolamide until the expiration date on the bottle, even after opening it.
Can dorzolamide cause any other side effects?
Besides the common side effects, some people have reported blurred vision, eye redness, tearing, dryness, and sensitivity to light. Other side effects are possible, so talk to your doctor if you have any concerns.
What if I am taking other medications?
Tell your doctor about all the medicines you take, including eye drops and pills. Dorzolamide can interact with some medicines.
Can dorzolamide cure my glaucoma?
Dorzolamide helps to control the pressure in your eye. It does not cure glaucoma, but it can help prevent it from getting worse.
What are the common side effects of dorzolamide?
The most commonly reported side effects of dorzolamide include Burning, stinging, or discomfort in the eye right after using the drops, Bitter taste in your mouth, Superficial punctate keratitis (small spots on the surface of the eye), Signs and symptoms of an allergic reaction in the eye. Based on 4,759 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does dorzolamide interact with other medications?
Yes, dorzolamide has 2 known drug interactions. Notable interactions include timolol, dorzolamide/timolol. Always inform your doctor about all medications you are taking.
What drug class is dorzolamide?
dorzolamide belongs to the Carbonic Anhydrase Inhibitor (Ophthalmic) drug class. It requires a prescription (Rx). This medicine treats high pressure inside your eye.
Is dorzolamide safe during pregnancy?
It is not known if dorzolamide is safe to use during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Carbonic Anhydrase Inhibitor (Ophthalmic)

Other drugs grouped near dorzolamide — same-class peers and common alternatives.

Compare dorzolamide vs aflibercept side-by-side →

Medication Guides

Related Health & Safety Data

Save on dorzolamide

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for dorzolamide

The FDA label for dorzolamide (sold under brand names such as Trusopt) classifies it as a prescription-only medication in the Carbonic Anhydrase Inhibitor (Ophthalmic) class. This medicine treats high pressure inside your eye. Official labeling lists 4 commonly reported side effects, including Burning, stinging, or discomfort in the eye right after using the drops, Bitter taste in your mouth, Superficial punctate keratitis (small spots on the surface of the eye).

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 4,759 voluntary reports. The database also lists 2 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $1.41.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: January 9, 2026

All federal data sources used on this page